Literature DB >> 10396232

Gynaecological effects of tamoxifen.

S M Ismail1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1999        PMID： 10396232      PMCID： PMC501045          DOI： 10.1136/jcp.52.2.83

Source DB:  PubMed          Journal:  J Clin Pathol        ISSN： 0021-9746            Impact factor:   3.411


× No keyword cloud information.
  82 in total

1.  Endocrine effects of adjuvant chemotherapy and long-term tamoxifen administration on node-positive patients with breast cancer.

Authors:  V C Jordan; N F Fritz; D C Tormey
Journal:  Cancer Res       Date:  1987-01-15       Impact factor: 12.701

2.  Breast cancer trial stopped early.

Authors:  D Josefson
Journal:  BMJ       Date:  1998-04-18

3.  The expression of insulin-like growth factor and its binding protein mRNA in the endometrium of postmenopausal patients with breast cancer receiving tamoxifen.

Authors:  T J Laatikainen; E I Tomás; R J Voutilainen
Journal:  Cancer       Date:  1995-10-15       Impact factor: 6.860

4.  Is there an association between long-term tamoxifen treatment and the development of carcinosarcoma (malignant mixed Müllerian tumor) of the uterus?

Authors:  M.J. Evans; N.E.I. Langlois; H.C. Kitchener; I.D. Miller
Journal:  Int J Gynecol Cancer       Date:  1995-07       Impact factor: 3.437

5.  Adjuvant tamoxifen therapy for early stage breast cancer and second primary malignancies. Stockholm Breast Cancer Study Group.

Authors:  L E Rutqvist; H Johansson; T Signomklao; U Johansson; T Fornander; N Wilking
Journal:  J Natl Cancer Inst       Date:  1995-05-03       Impact factor: 13.506

6.  In vivo inhibition of insulin-like growth factor I gene expression by tamoxifen.

Authors:  H T Huynh; E Tetenes; L Wallace; M Pollak
Journal:  Cancer Res       Date:  1993-04-15       Impact factor: 12.701

7.  Genotoxic potential of tamoxifen and analogues in female Fischer F344/n rats, DBA/2 and C57BL/6 mice and in human MCL-5 cells.

Authors:  I N White; F de Matteis; A Davies; L L Smith; C Crofton-Sleigh; S Venitt; A Hewer; D H Phillips
Journal:  Carcinogenesis       Date:  1992-12       Impact factor: 4.944

8.  High-grade endometrial carcinoma in tamoxifen-treated breast cancer patients.

Authors:  U Magriples; F Naftolin; P E Schwartz; M L Carcangiu
Journal:  J Clin Oncol       Date:  1993-03       Impact factor: 44.544

9.  Prevention of breast cancer with tamoxifen: preliminary findings from the Italian randomised trial among hysterectomised women. Italian Tamoxifen Prevention Study.

Authors:  U Veronesi; P Maisonneuve; A Costa; V Sacchini; C Maltoni; C Robertson; N Rotmensz; P Boyle
Journal:  Lancet       Date:  1998-07-11       Impact factor: 79.321

10.  Abnormalities detected on transvaginal ultrasonography in tamoxifen-treated postmenopausal breast cancer patients may represent endometrial cystic atrophy.

Authors:  K F McGonigle; S L Shaw; S A Vasilev; T Odom-Maryon; S Roy; J F Simpson
Journal:  Am J Obstet Gynecol       Date:  1998-06       Impact factor: 8.661
View more
  8 in total

Review 1.  Comparative tolerability of first-generation selective estrogen receptor modulators in breast cancer treatment and prevention.

Authors:  M G Curtis
Journal:  Drug Saf       Date:  2001       Impact factor: 5.606

2.  The effects of tamoxifen on proliferation and steroid receptor expression in postmenopausal endometrium.

Authors:  M J E Mourits; K A Ten Hoor; A G J van der Zee; P H B Willemse; E G E de Vries; H Hollema
Journal:  J Clin Pathol       Date:  2002-07       Impact factor: 3.411

3.  Tumorigenic effects of tamoxifen on the female genital tract.

Authors:  Kaei Nasu; Noriyuki Takai; Masakazu Nishida; Hisashi Narahara
Journal:  Clin Med Pathol       Date:  2008-03-01

4.  Solitary uterine metastasis of invasive lobular carcinoma after adjuvant endocrine therapy: a case report.

Authors:  Masafumi Toyoshima; Hideki Iwahashi; Takashi Shima; Atsushi Hayasaka; Takako Kudo; Hiromitsu Makino; Saori Igeta; Rui Matsuura; Nobuko Ishigaki; Kozo Akagi; Junko Sakurada; Hiroyoshi Suzuki; Kosuke Yoshinaga
Journal:  J Med Case Rep       Date:  2015-02-14

5.  Feature of amenorrhea in postoperative tamoxifen users with breast cancer.

Authors:  Hoon Kim; Wonshik Han; Seung Yup Ku; Chang Suk Suh; Seok Hyun Kim; Young Min Choi
Journal:  J Gynecol Oncol       Date:  2016-10-27       Impact factor: 4.401

6.  Isolated uterine metastasis of invasive ductal carcinoma.

Authors:  Deniz Arslan; Deniz Tural; Ali Murat Tatlı; Emre Akar; Mükremin Uysal; Gülgün Erdoğan
Journal:  Case Rep Oncol Med       Date:  2013-03-14

7.  Endometrial Metastasis from Breast Cancer during Adjuvant Endocrine Therapy.

Authors:  Fumikata Hara; Sachiko Kiyoto; Daisuke Takabatake; Seiki Takashima; Kenjiro Aogi; Shozo Ohsumi; Norihiro Teramoto; Rieko Nishimura; Shigemitsu Takashima
Journal:  Case Rep Oncol       Date:  2010-04-29

Review 8.  The effect of tamoxifen on the genital tract.

Authors:  Sandra A Polin; Susan M Ascher
Journal:  Cancer Imaging       Date:  2008-06-30       Impact factor: 3.909
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.